Publications from OUS - Melanoma research group

36 publications found

1. Reis Costa D, Winge-Main AK, Skog A, Tsuruda KM, Robsahm TE, Kulle Andreassen B (2024)
   From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway
   Acta Oncol, 63, 965-973
   DOI 10.2340/1651-226X.2024.41266, PubMed 39690735
2. Eide NA, Noer A, Jespersen H, Jebsen P, Geisler J (2024)
   Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after Enucleation
   Case Rep Oncol, 17 (1), 1131-1139
   DOI 10.1159/000541341, PubMed 39474560
3. Frich L, Hermann R, Ryder T (2024)
   Breast implant-associated anaplastic large cell lymphoma
   Tidsskr Nor Laegeforen, 144 (12)
   DOI 10.4045/tidsskr.24.0315, PubMed 39404238
4. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
   Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
   Med Phys, 50 (8), 5294
   DOI 10.1002/mp.16594, PubMed 37573581
5. Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
   Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
   Clin Transl Radiat Oncol, 41, 100597
   DOI 10.1016/j.ctro.2023.100597, PubMed 37441544
6. Sah VR, Jespersen H, Karlsson J, Nilsson LM, Bergqvist M, Johansson I, Carneiro A, Helgadottir H, Levin M, Ullenhag G, Ståhlberg A, Olofsson Bagge R, Nilsson JA, Ny L (2023)
   Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
   Cancer Res Commun, 3 (5), 884-895
   DOI 10.1158/2767-9764.CRC-22-0490, PubMed 37377898
7. Winge-Main A, Robsahm TE, Nyakas M, Festervoll G, Torkilseng E, Thybo S, Pati S, Carroll R (2023)
   Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
   Future Oncol, 19 (3), 205-215
   DOI 10.2217/fon-2022-0969, PubMed 36974621
8. Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
   2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
   Front Neuroinform, 16, 1056068
   DOI 10.3389/fninf.2022.1056068, PubMed 36743439
9. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
   Correction: Melanoma - investigation and primary treatment
   Tidsskr Nor Laegeforen, 142 (1)
   DOI 10.4045/tidsskr.22.0806, PubMed 36655962
10. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
    Melanoma - investigation and primary treatment
    Tidsskr Nor Laegeforen, 142 (15)
    DOI 10.4045/tidsskr.22.0043, PubMed 36286571
11. Jespersen H (2022)
    Moles and melanoma
    Tidsskr Nor Laegeforen, 142 (15)
    DOI 10.4045/tidsskr.22.0626, PubMed 36286558
12. Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
    Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
    ESMO Open, 7 (5), 100588
    DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420
13. Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
    Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
    Int J Cancer, 150 (1), 100-111
    DOI 10.1002/ijc.33768, PubMed 34449877
14. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
    MRI pulse sequence integration for deep-learning-based brain metastases segmentation
    Med Phys, 48 (10), 6020-6035
    DOI 10.1002/mp.15136, PubMed 34405896
15. Heck A, Winge-Main AK (2021)
    Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
    BMJ Case Rep, 14 (5)
    DOI 10.1136/bcr-2021-241981, PubMed 34045201
16. Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
    Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
    NPJ Digit Med, 4 (1), 33
    DOI 10.1038/s41746-021-00398-4, PubMed 33619361
17. Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
    Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
    Phys Med Biol, 65 (22), 225020
    DOI 10.1088/1361-6560/abb71a, PubMed 33200748
18. Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
    Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
    Neurooncol Adv, 2 (1), vdaa028
    DOI 10.1093/noajnl/vdaa028, PubMed 32642687
19. Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
    Soluble AXL as a marker of disease progression and survival in melanoma
    PLoS One, 15 (1), e0227187
    DOI 10.1371/journal.pone.0227187, PubMed 31917795
20. Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T, Shivalingam B, Long GV, Menzies AM, Hruby G, Drummond KJ, Mandel C, Middleton MR, Reisse CH, Paton EJ, Steel V, Williams NC, Scolyer RA, Morton RL, Thompson JF (2019)
    Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
    J Clin Oncol, 37 (33), 3132-3141
    DOI 10.1200/JCO.19.01414, PubMed 31553661
21. Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
    Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    Clin Exp Immunol, 197 (1), 74-82
    DOI 10.1111/cei.13283, PubMed 30821848
22. Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
    Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
    Adv Radiat Oncol, 3 (4), 559-567
    DOI 10.1016/j.adro.2018.05.005, PubMed 30370356
23. Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
    Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
    J Am Acad Dermatol, 79 (1), 118-125.e1
    DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861
24. Fogarty GB, Hong A, Dolven-Jacobsen K, Reisse CH, Burmeister B, Haydu LH, Dhillon H, Steel V, Shivalingam B, Drummond K, Vardy J, Nowak A, Hruby G, Scolyer RA, Mandel C, Thompson JF (2015)
    First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
    BMC Res Notes, 8, 192
    DOI 10.1186/s13104-015-1153-5, PubMed 25952979
25. Fogarty GB, Hong A, Jacobsen KD, Reisse CH, Shivalingam B, Burmeister B, Haydu LE, Paton E, Thompson JF (2014)
    Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
    BMC Res Notes, 7, 412
    DOI 10.1186/1756-0500-7-412, PubMed 24981506
26. Hong AM, Suo C, Valenzuela M, Haydu LE, Jacobsen KD, Reisse CH, Fogarty G (2014)
    Low incidence of melanoma brain metastasis in the hippocampus
    Radiother Oncol, 111 (1), 59-62
    DOI 10.1016/j.radonc.2014.01.012, PubMed 24560764
27. Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA (2013)
    Malignant melanoma--diagnosis, treatment and follow-up in Norway
    Tidsskr Nor Laegeforen, 133 (20), 2154-9
    DOI 10.4045/tidsskr.12.1416, PubMed 24172628
28. Jacobsen KD, Tausjø J, Hager B, Gundersen S (2010)
    [Treatment of metastatic malignant melanoma localized to an extremity]
    Tidsskr Nor Laegeforen, 130 (1), 21-4
    DOI 10.4045/tidsskr.09.0701, PubMed 20094118
29. Jacobsen KD, Fosså SD, Aamdal S (2006)
    [Malignant melanoma--diagnosis and treatment]
    Tidsskr Nor Laegeforen, 126 (23), 3094-7
    PubMed 17160112
30. Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
    Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
    Eur Urol, 42 (3), 229-38; discussion 237-8
    DOI 10.1016/s0302-2838(02)00274-9, PubMed 12234507
31. Jacobsen KD, Theodorsen L, Fossa SD (2001)
    Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
    J Urol, 165 (1), 93-6
    DOI 10.1097/00005392-200101000-00023, PubMed 11125372
32. Jacobsen KD, Fosså SD (2000)
    Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle
    Eur Urol, 38 (6), 725-6;discussion 727
    DOI 10.1159/000020369, PubMed 11111191
33. Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD (1999)
    Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
    Br J Cancer, 80 (1-2), 249-55
    DOI 10.1038/sj.bjc.6690347, PubMed 10390004
34. Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
    A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
    Pathol Res Pract, 193 (7), 471-8
    DOI 10.1016/s0344-0338(97)80099-4, PubMed 9342752
35. Jacobsen KD, Olsen DR, Fosså K, Fosså SD (1997)
    External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
    Int J Radiat Oncol Biol Phys, 38 (1), 95-102
    DOI 10.1016/s0360-3016(96)00597-4, PubMed 9212009
36. Jacobsen KD, Follerås G, Fosså SD (1994)
    Metastases from renal cell carcinoma to the humerus or the shoulder girdle
    Br J Urol, 73 (2), 124-8
    DOI 10.1111/j.1464-410x.1994.tb07478.x, PubMed 8131012